These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25017254)

  • 41. EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells.
    Zhao Y; Wang XX; Wu W; Long H; Huang J; Wang Z; Li T; Tang S; Zhu B; Chen D
    Biochem Biophys Res Commun; 2019 Sep; 517(2):201-209. PubMed ID: 31331645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients.
    Kaya AO; Gunel N; Benekli M; Akyurek N; Buyukberber S; Tatli H; Coskun U; Yildiz R; Yaman E; Ozturk B
    J BUON; 2012; 17(4):663-8. PubMed ID: 23335522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
    Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
    Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis.
    Jiang T; Wang Y; Zhou F; Gao G; Ren S; Zhou C
    Oncotarget; 2016 Jan; 7(4):4584-97. PubMed ID: 26683709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of RAP1B is associated with poor prognosis and promotes an aggressive phenotype in gastric cancer.
    Yang Y; Li M; Yan Y; Zhang J; Sun K; Qu JK; Wang JS; Duan XY
    Oncol Rep; 2015 Nov; 34(5):2385-94. PubMed ID: 26329876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer.
    Reijm EA; Jansen MP; Ruigrok-Ritstier K; van Staveren IL; Look MP; van Gelder ME; Sieuwerts AM; Sleijfer S; Foekens JA; Berns EM
    Breast Cancer Res Treat; 2011 Jan; 125(2):387-94. PubMed ID: 20306127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer.
    Cai FF; Xu C; Pan X; Cai L; Lin XY; Chen S; Biskup E
    Oncotarget; 2016 Nov; 7(47):77793-77806. PubMed ID: 27780920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxia-inducible factor-1α and semaphorin4D genes involved with tumor-associated macrophage-induced metastatic behavior and clinical significance in colon cancer.
    Mu L; Wang J; Chen Y; Li L; Guo X; Zheng S; Jing C
    Chin Med J (Engl); 2014; 127(20):3568-75. PubMed ID: 25316231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
    Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
    Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
    Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
    Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.
    Kim HO; Jo YH; Lee J; Lee SS; Yoon KS
    Oncol Rep; 2008 Nov; 20(5):1181-7. PubMed ID: 18949419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma.
    Valencak J; Kittler H; Schmid K; Schreiber M; Raderer M; Gonzalez-Inchaurraga M; Birner P; Pehamberger H
    Clin Exp Dermatol; 2009 Dec; 34(8):e962-4. PubMed ID: 20055873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients.
    Wu Z; Wang Q; Wang L; Li G; Liu H; Fan F; Li Z; Li Y; Tu Y
    J Neurol Sci; 2013 Dec; 335(1-2):191-6. PubMed ID: 24139839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
    Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
    Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of Nrf2 and HIF-1α in glioblastoma and their relationships to clinicopathologic features and survival.
    Ji X; Wang H; Zhu J; Tang Y; Zhou Y; Zhu L; Gao C; Li W; You W; Yu B; Xia Q
    Neurol Res; 2013 Dec; 35(10):1044-50. PubMed ID: 24070025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy.
    Chen L; Shi Y; Yuan J; Han Y; Qin R; Wu Q; Jia B; Wei B; Wei L; Dai G; Jiao S
    PLoS One; 2014; 9(3):e90678. PubMed ID: 24614305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.
    Huqun ; Ishikawa R; Zhang J; Miyazawa H; Goto Y; Shimizu Y; Hagiwara K; Koyama N
    Cancer; 2012 Mar; 118(6):1599-606. PubMed ID: 21837672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
    Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
    Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.